ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4,868.1% | -9,792.9% | -4,901.6% | – | – | – | – | – | – | – | -74.1% | – | |
| 349.7% | 236.1% | 124.5% | – | – | – | – | – | – | – | 2.6% | – | |
| – | – | – | – | – | – | – | – | – | – | 8.5% | – | |
| 1,029.4% | -1,464.9% | -282.3% | – | – | – | – | – | – | – | -37.0% | – | |
| 3.2% | 163.5% | 0.0% | – | – | – | – | – | – | – | 0.0% | – | |
| 646.9% | -346.1% | – | – | – | – | – | – | – | – | 0.6% | – | |
| – | – | – | – | – | – | – | – | – | – | 48.1% | – | |
| 8,730.2% | 6,436.8% | 1,536.5% | – | – | – | – | – | – | – | 54.1% | – | |
| 4,509.0% | -3,702.3% | -3,365.1% | – | – | – | – | – | – | – | -19.5% | – | |
| -4,871.3% | -9,956.5% | -4,901.6% | – | – | – | – | – | – | – | -74.1% | – |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.